These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2582741)

  • 1. In vivo chemotaxis of oxidised lipids: 1. Chemotactic effects of oxidised arachidonic acid on rat leucocytes.
    Onyia KA
    Comp Immunol Microbiol Infect Dis; 1989; 12(3):77-82. PubMed ID: 2582741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcal protein A (SpA): a potent in vivo chemotactic agent for rat leucocytes.
    Onyia KA
    Comp Immunol Microbiol Infect Dis; 1988; 11(1):21-6. PubMed ID: 3383551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo chemotaxis of rat leucocytes to N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP).
    Onyia KA
    Comp Immunol Microbiol Infect Dis; 1987; 10(1):33-9. PubMed ID: 3581774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucocyte migration into cotton pellets: a new in vivo method for the study of chemotaxis and leucocytic migration.
    Onyia KA
    Comp Immunol Microbiol Infect Dis; 1986; 9(1):79-88. PubMed ID: 3769443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphonulcear leukocyte chemotaxis toward oxidized lipid components of cell membranes.
    Turner SR; Campbell JA; Lynn WS
    J Exp Med; 1975 Jun; 141(6):1437-41. PubMed ID: 1127383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo chemotaxis of bovine neutrophils induced by 5-lipoxygenase metabolites of arachidonic and eicosapentaenoic acid.
    Heidel JR; Taylor SM; Laegreid WW; Silflow RM; Liggitt HD; Leid RW
    Am J Pathol; 1989 Mar; 134(3):671-6. PubMed ID: 2538061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of the polymorphonuclear leukocyte chemotactic response to hydroxy-fatty acid metabolites of arachidonic acid by methyl ester derivatives.
    Goetzl EJ; Valone FH; Reinhold VN; Gorman RR
    J Clin Invest; 1979 Jun; 63(6):1181-6. PubMed ID: 447841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired chemotactic responses of bronchoalveolar leukocytes in experimental pneumoconiosis.
    Donaldson K; Brown GM; Brown DM; Slight J; Robertson MD; Davis JM
    J Pathol; 1990 Jan; 160(1):63-9. PubMed ID: 2156037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of some anti-inflammatory drugs on FMLP-induced chemotaxis and random migration of rat polymorphonuclear leucocytes.
    Pham Huy D; Roch-Arveiller M; Muntaner O; Giroud JP
    Eur J Pharmacol; 1985 May; 111(2):251-6. PubMed ID: 4018130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of arachidonic acid derivatives in neutrophil aggregation: a hypothesis.
    O'Flaherty JT; Showell HJ; Becker EL; Ward PA
    Prostaglandins; 1979 Jun; 17(6):915-27. PubMed ID: 504694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linoleic acid and arachidonic acid metabolism in human peripheral blood leucocytes: comparison with the rat.
    Cunnane SC; Keeling PW; Thompson RP; Crawford MA
    Br J Nutr; 1984 Mar; 51(2):209-17. PubMed ID: 6422980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo effects of nonsteroidal antiinflammatory drugs on arachidonic acid metabolism in neutrophils from a reverse passive Arthus reaction.
    Myers RF; Anthes JC; Casmer CJ; Siegel MI
    Inflammation; 1985 Mar; 9(1):91-8. PubMed ID: 3156814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural requirements for the activity of an immunologically generated lipid chemotactic factor.
    Valone FH; Goetzl EJ
    Immunology; 1980 Nov; 41(3):517-24. PubMed ID: 6780447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence in the rat of counter-irritation by turpentine on the leukocyte content of exudates induced by sponge implants].
    Deflandre E; Damas J
    J Pharmacol; 1986; 17(2):155-62. PubMed ID: 3091943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of neutrophil chemotaxis by organotin compounds.
    Arakawa Y; Wada O
    Biochem Biophys Res Commun; 1984 Sep; 123(2):543-8. PubMed ID: 6435615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acid.
    König W; Tesch H; Frickhofen N
    Eur J Immunol; 1978 Jun; 8(6):434-7. PubMed ID: 352712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel and highly potent eosinophil chemotactic lipid in human eosinophils treated with arachidonic acid.
    Morita E; Schröder JM; Christophers E
    J Immunol; 1990 Mar; 144(5):1893-900. PubMed ID: 2155268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulus-specificity of the chemotactic deactivation of human neutrophils by lipoxygenase products of arachidonic acid.
    Goetzl EJ; Boeynaems JM; Oates JA; Hubbard WC
    Prostaglandins; 1981 Aug; 22(2):279-88. PubMed ID: 6270743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid.
    Goetzl EJ; Goldman DW; Naccache PH; Sha'afi RI; Pickett WC
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():273-82. PubMed ID: 6283846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotactic factor receptors of human PMN leucocytes. I. Effects on migration of labelling plasma membrane determinants with impermeant covalent reagents and inhibition of labelling by chemotactic factors.
    Goetzl EJ; Hoe KY
    Immunology; 1979 Jun; 37(2):407-18. PubMed ID: 89083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.